Skip to content
10-K

Annual Report

Juno Therapeutics, Inc.

0001594864-17-000009

← back to feed
Filed
Mar 1, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Feb 22, 2017 106.02M sh
Current Liabilities FY 2016 · Dec 31, 2015 $119.73M
Current Assets FY 2016 · Dec 31, 2015 $951.84M
Total Assets FY 2016 · Dec 31, 2015 $1.45B
Net Income FY 2016 · Dec 31, 2015 −$85.21M
Net Income FY 2016 · Sep 30, 2015 −$23.24M
Net Income FY 2016 · Jun 30, 2015 −$65.96M
Net Income FY 2016 · Mar 31, 2015 −$64.97M
Net Income FY 2016 · Dec 31, 2014 −$243.41M
Operating Income FY 2016 · Dec 31, 2015 −$87.44M
Operating Income FY 2016 · Sep 30, 2015 −$23.53M
Operating Income FY 2016 · Jun 30, 2015 −$67.97M
Operating Income FY 2016 · Mar 31, 2015 −$65.16M
Operating Income FY 2016 · Dec 31, 2014 −$232.76M
Stock Repurchased FY 2016 · Dec 31, 2014 $0
Capex FY 2016 · Dec 31, 2014 $2.96M
Operating Cash Flow FY 2016 · Dec 31, 2014 −$82.55M
Sga Expense restated FY 2016 · Dec 31, 2014 $28.25M
Rd Expense FY 2016 · Dec 31, 2014 $204.51M
Revenue FY 2016 · Dec 31, 2014 $0
Cash And Equivalents FY 2016 · Dec 31, 2013 $35.97M
Stockholders Equity FY 2016 · Dec 31, 2013 −$43.68M